Immunotherapy Gets ‘Meaningful’ Survival Win in Operable Gastric Cancer

By News Health
5 hours Ago

(MedPage Today) — BERLIN — In a global phase III trial, the addition of durvalumab (Imfinzi) to standard chemotherapy given before and after surgery led to a statistically significant and “clinically meaningful” survival improvement in patients…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118009

Author :

Publish date : 2025-10-17 20:23:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

'An adult weekender at Butlin's saved my life'

Exciting results from blood test for 50 cancers

Gene Therapy Shows Lasting Benefit for Children With Rare Disorder

Government Shutdown, Funding Cuts Threaten U.S. Disaster Preparedness, Experts Say

Does the AMA Have a Seat at Trump's Table?

Another 'Practice-Changing' Study in High-Risk Bladder Cancer